Selected article for: "gene expression and negative weight"

Author: Noh, Heeju; Shoemaker, Jason E; Gunawan, Rudiyanto
Title: Network perturbation analysis of gene transcriptional profiles reveals protein targets and mechanism of action of drugs and influenza A viral infection
  • Document date: 2018_4_6
  • ID: j80hnhpb_42
    Snippet: ProTINA takes advantage of the availability of comprehensive protein-protein and protein-DNA interaction databases to construct, when possible, a tissue or cell type-specific PGRN. The method considers a PGRN with weighted directed edges (see Figure 1A) , describing direct and indirect gene transcriptional regulation by TFs and their protein partners. The edge weights are determined by applying ridge regression using the gene expression data base.....
    Document: ProTINA takes advantage of the availability of comprehensive protein-protein and protein-DNA interaction databases to construct, when possible, a tissue or cell type-specific PGRN. The method considers a PGRN with weighted directed edges (see Figure 1A) , describing direct and indirect gene transcriptional regulation by TFs and their protein partners. The edge weights are determined by applying ridge regression using the gene expression data based on a kinetic model of the gene transcriptional process (see Figure 1B and Materials and Methods). Here, a positive weight indicates a gene activation, while a negative weight implies a gene repression. Because of the underlying kinetic model, ProTINA is able to incorporate dynamical gene expression data, a common type of data from drug treatment studies (5, (24) (25) (26) . The scoring of drug targets is based on the enhancement or attenuation of protein-gene regulatory interactions caused by the drug treatment. A drug-induced gene regulatory enhancement occurs when the expression of genes that are positively (negatively) regulated by a candidate target, becomes higher (lower) in drug treated samples than what is predicted by the PGRN model (see Figure 1C) . A drug-induced attenuation describes the opposite scenario, where the expression of positively (negatively) regulated genes of a target is lower (higher) than expected from the model. For any given differential gene expression sample, a candidate protein target is scored based on the overall enhancement and/or attenuation of its regulatory influence on the downstream genes (see Figure 1D and Materials and Methods). Thus, a protein target with a more positive (negative) score is considered a more likely target of the drug, in which the drug treatment enhances (attenuates) the gene regulatory activity.

    Search related documents:
    Co phrase search for related documents
    • protein protein and regulatory enhancement: 1
    • protein protein and regulatory influence: 1
    • protein protein and regulatory interaction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • protein protein and transcriptional process: 1, 2, 3, 4
    • protein target and regulatory activity: 1
    • protein target and regulatory enhancement: 1
    • protein target and regulatory interaction: 1, 2, 3, 4
    • protein target and transcriptional process: 1
    • protein target and transcriptional regulation: 1, 2, 3
    • protein target and type specific pgrn: 1
    • regulatory activity and transcriptional process: 1
    • regulatory activity and transcriptional regulation: 1, 2, 3, 4, 5
    • regulatory enhancement and transcriptional process: 1
    • regulatory enhancement and transcriptional regulation: 1
    • regulatory enhancement and type specific pgrn: 1
    • regulatory interaction and transcriptional process: 1
    • regulatory interaction and transcriptional regulation: 1
    • ridge regression and type specific pgrn: 1, 2
    • transcriptional process and type specific pgrn: 1, 2